Mark F. Van Delft

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

Journal: Blood
Published: March 25, 2026

Differential regulation of BAX and BAK apoptotic activity revealed by small molecules.

Differential regulation of BAX and BAK apoptotic activity revealed by small molecules.

Journal: Science advances
Published: March 05, 2025

Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

Journal: Cell death and differentiation
Published: July 05, 2024

Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis.

Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis.

Journal: PLoS biology
Published: December 23, 2023

Improved drug target deconvolution with PISA-DIA using an extended, overlapping temperature gradient.

Improved drug target deconvolution with PISA-DIA using an extended, overlapping temperature gradient.

Journal: Proteomics
Published: December 19, 2023

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase.

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase.

Journal: The Biochemical journal
Published: February 09, 2023

Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteins.

Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteins.

Journal: Cell death and differentiation
Published: May 03, 2022

Too much death can kill you: inhibiting intrinsic apoptosis to treat disease.

Too much death can kill you: inhibiting intrinsic apoptosis to treat disease.

Journal: The EMBO journal
Published: February 02, 2021

Potent Inhibition of Necroptosis by Simultaneously Targeting Multiple Effectors of the Pathway.

Potent Inhibition of Necroptosis by Simultaneously Targeting Multiple Effectors of the Pathway.

Journal: ACS chemical biology
Published: September 09, 2020

The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.

The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.

Journal: Cell death & disease
Published: August 24, 2020

The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival.

The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival.

Journal: Leukemia
Published: May 06, 2020

MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex.

MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex.

Journal: Cell death and differentiation
Published: July 03, 2019
Showing 1-12 of 22

Last Updated: 09/26/2026